Hi ,
Interesting the FDA are on Mercks case for patient deaths in their combination trials.
With Cavatak it's next to none for adverse affects.
More on Fiercepharma if interested.
Aloha.
- Forums
- ASX - By Stock
- Gilead buys Kite Pharma for $11.9 BN
Hi , Interesting the FDA are on Mercks case for patient deaths...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online